指南与共识类风湿关节炎其他结缔组织病

2023年美国风湿病学会(ACR)/美国胸科医师学会(CHEST)指南:系统性自身免疫性风湿病患者间质性肺病的筛查与监测

2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases.
指南 / 共识 · Arthritis Rheumatol · 2024-07-08

本指南针对类风湿关节炎、系统性硬化症、特发性炎性肌病、混合性结缔组织病和舍格伦病患者,通过系统文献回顾与GRADE方法形成15条推荐,涵盖间质性肺病筛查与监测的检查选择及检测频率建议。

要点

  • 对间质性肺病风险的上述系统性自身免疫性风湿病患者,有条件推荐用肺功能检查和高分辨率胸部CT筛查。
  • 有条件推荐反对用6分钟步行距离、胸部X线、步行血氧饱和度下降试验或支气管镜筛查,强烈推荐反对用外科肺活检筛查。
  • 有条件推荐用肺功能检查、高分辨率胸部CT和步行血氧饱和度下降试验监测间质性肺病,有条件推荐反对用6分钟步行距离、胸部X线或支气管镜监测。

核心结论

  • 本临床实践指南提出美国风湿病学会与美国胸科医师学会认可的首批关于系统性自身免疫性风湿病患者间质性肺病筛查与监测的推荐。

研究设计与样本

  • 针对类风湿关节炎、系统性硬化症、特发性炎性肌病、混合性结缔组织病和舍格伦病患者,构建间质性肺病筛查与监测的临床相关问题,进行系统文献回顾,采用GRADE方法评级证据,由跨学科临床专家与患者组成的投票小组就每条推荐的方向与强度达成共识,共形成15条推荐。

主要发现

  • 筛查方面:有条件推荐肺功能检查和高分辨率胸部CT;有条件推荐反对6分钟步行距离、胸部X线、步行血氧饱和度下降试验或支气管镜筛查;强烈推荐反对外科肺活检筛查。
  • 监测方面:有条件推荐肺功能检查、高分辨率胸部CT和步行血氧饱和度下降试验;有条件推荐反对6分钟步行距离、胸部X线或支气管镜监测。
  • 指南还就间质性肺病危险因素及评估间质性肺病发生的检测频率给出指导与建议。

关键数值与推荐

  • 对间质性肺病风险的系统性自身免疫性风湿病患者筛查:有条件推荐肺功能检查、高分辨率胸部CT。
  • 筛查:有条件推荐反对6分钟步行距离、胸部X线、步行血氧饱和度下降试验、支气管镜;强烈推荐反对外科肺活检。
  • 监测:有条件推荐肺功能检查、高分辨率胸部CT、步行血氧饱和度下降试验;有条件推荐反对6分钟步行距离、胸部X线、支气管镜。

临床怎么用

  • 对类风湿关节炎、系统性硬化症、特发性炎性肌病、混合性结缔组织病和舍格伦病等系统性自身免疫性风湿病患者的间质性肺病筛查,可按指南有条件推荐采用肺功能检查与高分辨率胸部CT,并避免以6分钟步行距离、胸部X线、步行血氧饱和度下降试验或支气管镜筛查,强烈推荐反对外科肺活检筛查。
  • 对已发现的间质性肺病监测,可按指南有条件推荐采用肺功能检查、高分辨率胸部CT与步行血氧饱和度下降试验,避免以6分钟步行距离、胸部X线或支气管镜监测;检测频率参照指南给出的建议。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We provide evidence-based recommendations regarding screening for interstitial lung disease (ILD) and the monitoring for ILD progression in people with systemic autoimmune rheumatic diseases (SARDs), specifically rheumatoid arthritis, systemic sclerosis, idiopathic inflammatory myopathies, mixed connective tissue disease, and Sjögren disease. METHODS: We developed clinically relevant population, intervention, comparator, and outcomes questions related to screening and monitoring for ILD in patients with SARDs. A systematic literature review was performed, and the available evidence was rated using the Grading of Recommendations, Assessment, Development, and Evaluation methodology. A Voting Panel of interdisciplinary clinician experts and patients achieved consensus on the direction and strength of each recommendation. RESULTS: Fifteen recommendations were developed. For screening people with these SARDs at risk for ILD, we conditionally recommend pulmonary function tests (PFTs) and high-resolution computed tomography of the chest (HRCT chest); conditionally recommend against screening with 6-minute walk test distance (6MWD), chest radiography, ambulatory desaturation testing, or bronchoscopy; and strongly recommend against screening with surgical lung biopsy. We conditionally recommend monitoring ILD with PFTs, HRCT chest, and ambulatory desaturation testing and conditionally recommend against monitoring with 6MWD, chest radiography, or bronchoscopy. We provide guidance on ILD risk factors and suggestions on frequency of testing to evaluate for the development of ILD in people with SARDs. CONCLUSION: This clinical practice guideline presents the first recommendations endorsed by the American College of Rheumatology and American College of Chest Physicians for the screening and monitoring of ILD in people with SARDs.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Johnson SR, Bernstein EJ, Bolster MB, et al. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024. PMID: 38973714. doi:10.1002/art.42860

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。